Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y(12) receptor inhibitor in patients undergoing percutaneous coronary intervention (PCI) reduces the risk of ischemic events but reduces the risk of ischemic events but increases the risk of bleeding, which in turn is associated with increased mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelliccia, Francesco, Gragnano, Felice, Pasceri, Vincenzo, Cesaro, Arturo, Zimarino, Marco, Calabrò, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267626/
https://www.ncbi.nlm.nih.gov/pubmed/35806860
http://dx.doi.org/10.3390/jcm11133574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267626/
https://www.ncbi.nlm.nih.gov/pubmed/35806860
http://dx.doi.org/10.3390/jcm11133574

Ejemplares similares